Amazon affiliate link
Alcohol pads
MED PRIDE, 70% isopropyl, 200 count per listing. An alcohol pad does not establish sterility of a research product.
View on Amazon ↗Metabolic and cellular research
AOD-9604
research guide
AOD-9604 is a synthetic fragment corresponding to amino acids 176 to 191 of human growth hormone, studied for its reported effect on fat metabolism without the growth-promoting activity of full-length growth hormone. Published animal studies in obese and lean mice found it increased fat oxidation and reduced body weight over a chronic dosing period, with effects the authors linked to beta-3 adrenergic receptor pathways [1][2]. No completed human randomized controlled trial with peer-reviewed published results was located in the Europe PMC search conducted for this page; no validated human protocol was found in the sources reviewed.
Laboratory or animal findings, not clinical validation. Literature summary, not clinical peer review.
Looking for the product? Reign listings and business disclosure ↓
Jorge Abreu is not a doctor. This is an educational research summary, not a prescription or a personal dosing plan. Study results do not establish that a supplier product is safe or effective for people. Consult a licensed clinician about medical decisions.
01 · Start with identity
What is AOD-9604?
AOD-9604 refers to a specific 16-amino-acid fragment of the human growth hormone sequence, chemically distinct from full-length growth hormone itself. Reign Peptide's product is a lyophilized research-chemical powder of this fragment sold for laboratory use, not an approved drug and not equivalent to full-length growth hormone.
Also searched as: Anti-Obesity Drug 9604, hGH fragment 176-191
02 · Read the evidence
What the studies reported
01
Fat metabolism effects in obese mice
Chronic intraperitoneal administration of AOD-9604 to obese mice for 14 days reduced body weight and body fat, an effect the authors associated with increased expression of beta-3 adrenergic receptor RNA, a pathway involved in fat breakdown; the effect was absent in beta-3 adrenergic receptor knock-out mice, though an acute dose of AOD-9604 still increased energy expenditure and fat oxidation in those knock-out mice. [1]
02
Fat oxidation in a separate rodent model
A separate study using mini-osmotic pumps to deliver AOD-9604 to obese and lean mice over 14 days found increased fat oxidation and reduced weight gain without the hyperglycemia or reduced insulin secretion seen with full-length growth hormone, and in vitro assays showed AOD-9604 did not bind the growth hormone receptor or stimulate cell proliferation the way full-length growth hormone did. [2]
03 · Numbers in context
What does dosing evidence actually support?
The dosing evidence identified for this compound is limited to rodent studies using chronic intraperitoneal administration via osmotic minipump over roughly two weeks in mouse obesity models [1][2]. No peer-reviewed completed human clinical trial results were located in the sources reviewed for this page, so there is no human dosing evidence to describe; any specific milligram schedule discussed elsewhere is not supported by the primary literature reviewed here.
A study dose is not a personal dose. Population, route, formulation and supervision are part of the result. Online community schedules are not treated here as established clinical protocols.
04 · Safety and limits
What not to overlook
- No completed human clinical trial with published peer-reviewed results was located in the sources reviewed; evidence here is limited to rodent studies.
- Effects described are specific to obese and genetically modified mouse models and may not translate directly to human physiology.
- No FDA-approved indication exists for AOD-9604.
- Long-term human safety data was not identified in the sources reviewed.
05 · Product distinctions
Names are not interchangeable
Reign Peptide sells AOD-9604 as a lyophilized powder vial (5mg) intended for laboratory research reconstitution. No approved pharmaceutical formulation of this fragment exists for direct comparison; the two mouse studies reviewed used chronic intraperitoneal dosing, one delivered via implanted mini-osmotic pumps, both different delivery methods than a manually reconstituted research vial.
06 · Handling and storage
Follow validated product instructions
A single water volume, refrigerator temperature or expiry window cannot be assumed for every compound and formulation. Use the exact manufacturer documentation and a validated laboratory procedure. If stability, solvent compatibility or microbiological quality is not documented, those properties remain unverified.
Refrigeration, clear appearance and bacteriostatic water do not make an unverified research product suitable for injection. This guide does not provide a mixing or administration procedure.
The existing concentration calculator checks arithmetic only. It cannot choose a safe dose or establish compatibility, sterility or shelf life.
Reign Peptide · Business disclosure
Research product listings
Jorge Abreu is involved in Reign Peptide. Links to Reign are a business connection, not an independent endorsement. Reign lists these products for laboratory research, not human consumption.
Use the listing to check the labeled identity, amount and available batch documentation. A purity result alone does not verify sterility, clinical suitability or equivalence to a medicine used in a trial.
Names and sizes are product labels, not dosing recommendations. Confirm current details with the seller.
Supplies and accessories
Compare the actual specifications
Jorge's supply directory includes syringes, alcohol pads, storage cases, travel refrigeration and electrolytes, with separate links for the two travel refrigeration options. Accessory availability is not a recommendation to administer a research compound.
Affiliate disclosure: As an Amazon Associate I earn from qualifying purchases.
Amazon affiliate link
Peptide fridge case
Listing: 63 slots for 3mL bottles, bag only. An organizer is not active refrigeration or a validated storage system.
View on Amazon ↗Amazon affiliate link
Peptide travel case
Medineed travel case with temperature display and two ice packs per listing. Check dimensions and transport requirements.
View on Amazon ↗Questions still worth asking
What remains unresolved?
- Has a completed, peer-reviewed human randomized controlled trial of AOD-9604 for fat metabolism been published since the rodent studies conducted in the early 2000s?
- Do the beta-3 adrenergic receptor mechanisms observed in mice operate the same way in human adipose tissue?
Check the source
References and evidence scope
- Animal study · 2001The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice ↗
- Animal study · 2001Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragment ↗
These are the sources reviewed for this page, not an exhaustive systematic review. Related compound research is identified as such. Product links are not scientific references.
Keep reading